Cargando…

Transient receptor potential melastatin 2 channels are overexpressed in myalgic encephalomyelitis/chronic fatigue syndrome patients

BACKGROUND: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is hallmarked by a significant reduction in natural killer (NK) cell cytotoxicity, a mechanism tightly regulated by calcium (Ca(2+)). Interestingly, interleukin-2 (IL-2) increases NK cell cytotoxicity. Transient receptor potenti...

Descripción completa

Detalles Bibliográficos
Autores principales: Balinas, Cassandra, Cabanas, Helene, Staines, Donald, Marshall-Gradisnik, Sonya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6891975/
https://www.ncbi.nlm.nih.gov/pubmed/31796045
http://dx.doi.org/10.1186/s12967-019-02155-4
_version_ 1783475936786644992
author Balinas, Cassandra
Cabanas, Helene
Staines, Donald
Marshall-Gradisnik, Sonya
author_facet Balinas, Cassandra
Cabanas, Helene
Staines, Donald
Marshall-Gradisnik, Sonya
author_sort Balinas, Cassandra
collection PubMed
description BACKGROUND: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is hallmarked by a significant reduction in natural killer (NK) cell cytotoxicity, a mechanism tightly regulated by calcium (Ca(2+)). Interestingly, interleukin-2 (IL-2) increases NK cell cytotoxicity. Transient receptor potential melastatin 2 (TRPM2) ion channels are fundamental for Ca(2+) signalling in NK cells. This pilot investigation aimed to characterise TRPM2 and CD38 surface expression in vitro on NK cells in ME/CFS patients. This investigation furthermore examined the pharmaceutical effect of 8-bromoadenosine phosphoribose (8-Br-ADPR) and N(6)-Benzoyladenosine-3′,5′-cyclic monophosphate (N(6)-Bnz-cAMP) on TRPM2 and CD38 surface expression and NK cell cytotoxicity between ME/CFS and healthy control (HC) participants. METHODS: Ten ME/CFS patients (43.45 ± 12.36) and 10 HCs (43 ± 12.27) were age and sex-matched. Isolated NK cells were labelled with fluorescent antibodies to determine baseline and drug-treated TRPM2 and CD38 surface expression on NK cell subsets. Following IL-2 stimulation, NK cell cytotoxicity was measured following 8-Br-ADPR and N(6)-Bnz-cAMP drug treatments by flow cytometry. RESULTS: Baseline TRPM2 and CD38 surface expression was significantly higher on NK cell subsets in ME/CFS patients compared with HCs. Post IL-2 stimulation, TRPM2 and CD38 surface expression solely decreased on the CD56(Dim)CD16(+) subset. 8-Br-ADPR treatment significantly reduced TRPM2 surface expression on the CD56(Bright)CD16(Dim/−) subset within the ME/CFS group. Baseline cell cytotoxicity was significantly reduced in ME/CFS patients, however no changes were observed post drug treatment in either group. CONCLUSION: Overexpression of TRPM2 on NK cells may function as a compensatory mechanism to alert a dysregulation in Ca(2+) homeostasis to enhance NK cell function in ME/CFS, such as NK cell cytotoxicity. As no improvement in NK cell cytotoxicity was observed within the ME/CFS group, an impairment in the TRPM2 ion channel may be present in ME/CFS patients, resulting in alterations in [Ca(2+)](i) mobilisation and influx, which is fundamental in driving NK cell cytotoxicity. Differential expression of TRPM2 between NK cell subtypes may provide evidence for their role in the pathomechanism involving NK cell cytotoxicity activity in ME/CFS.
format Online
Article
Text
id pubmed-6891975
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-68919752019-12-11 Transient receptor potential melastatin 2 channels are overexpressed in myalgic encephalomyelitis/chronic fatigue syndrome patients Balinas, Cassandra Cabanas, Helene Staines, Donald Marshall-Gradisnik, Sonya J Transl Med Research BACKGROUND: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is hallmarked by a significant reduction in natural killer (NK) cell cytotoxicity, a mechanism tightly regulated by calcium (Ca(2+)). Interestingly, interleukin-2 (IL-2) increases NK cell cytotoxicity. Transient receptor potential melastatin 2 (TRPM2) ion channels are fundamental for Ca(2+) signalling in NK cells. This pilot investigation aimed to characterise TRPM2 and CD38 surface expression in vitro on NK cells in ME/CFS patients. This investigation furthermore examined the pharmaceutical effect of 8-bromoadenosine phosphoribose (8-Br-ADPR) and N(6)-Benzoyladenosine-3′,5′-cyclic monophosphate (N(6)-Bnz-cAMP) on TRPM2 and CD38 surface expression and NK cell cytotoxicity between ME/CFS and healthy control (HC) participants. METHODS: Ten ME/CFS patients (43.45 ± 12.36) and 10 HCs (43 ± 12.27) were age and sex-matched. Isolated NK cells were labelled with fluorescent antibodies to determine baseline and drug-treated TRPM2 and CD38 surface expression on NK cell subsets. Following IL-2 stimulation, NK cell cytotoxicity was measured following 8-Br-ADPR and N(6)-Bnz-cAMP drug treatments by flow cytometry. RESULTS: Baseline TRPM2 and CD38 surface expression was significantly higher on NK cell subsets in ME/CFS patients compared with HCs. Post IL-2 stimulation, TRPM2 and CD38 surface expression solely decreased on the CD56(Dim)CD16(+) subset. 8-Br-ADPR treatment significantly reduced TRPM2 surface expression on the CD56(Bright)CD16(Dim/−) subset within the ME/CFS group. Baseline cell cytotoxicity was significantly reduced in ME/CFS patients, however no changes were observed post drug treatment in either group. CONCLUSION: Overexpression of TRPM2 on NK cells may function as a compensatory mechanism to alert a dysregulation in Ca(2+) homeostasis to enhance NK cell function in ME/CFS, such as NK cell cytotoxicity. As no improvement in NK cell cytotoxicity was observed within the ME/CFS group, an impairment in the TRPM2 ion channel may be present in ME/CFS patients, resulting in alterations in [Ca(2+)](i) mobilisation and influx, which is fundamental in driving NK cell cytotoxicity. Differential expression of TRPM2 between NK cell subtypes may provide evidence for their role in the pathomechanism involving NK cell cytotoxicity activity in ME/CFS. BioMed Central 2019-12-03 /pmc/articles/PMC6891975/ /pubmed/31796045 http://dx.doi.org/10.1186/s12967-019-02155-4 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Balinas, Cassandra
Cabanas, Helene
Staines, Donald
Marshall-Gradisnik, Sonya
Transient receptor potential melastatin 2 channels are overexpressed in myalgic encephalomyelitis/chronic fatigue syndrome patients
title Transient receptor potential melastatin 2 channels are overexpressed in myalgic encephalomyelitis/chronic fatigue syndrome patients
title_full Transient receptor potential melastatin 2 channels are overexpressed in myalgic encephalomyelitis/chronic fatigue syndrome patients
title_fullStr Transient receptor potential melastatin 2 channels are overexpressed in myalgic encephalomyelitis/chronic fatigue syndrome patients
title_full_unstemmed Transient receptor potential melastatin 2 channels are overexpressed in myalgic encephalomyelitis/chronic fatigue syndrome patients
title_short Transient receptor potential melastatin 2 channels are overexpressed in myalgic encephalomyelitis/chronic fatigue syndrome patients
title_sort transient receptor potential melastatin 2 channels are overexpressed in myalgic encephalomyelitis/chronic fatigue syndrome patients
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6891975/
https://www.ncbi.nlm.nih.gov/pubmed/31796045
http://dx.doi.org/10.1186/s12967-019-02155-4
work_keys_str_mv AT balinascassandra transientreceptorpotentialmelastatin2channelsareoverexpressedinmyalgicencephalomyelitischronicfatiguesyndromepatients
AT cabanashelene transientreceptorpotentialmelastatin2channelsareoverexpressedinmyalgicencephalomyelitischronicfatiguesyndromepatients
AT stainesdonald transientreceptorpotentialmelastatin2channelsareoverexpressedinmyalgicencephalomyelitischronicfatiguesyndromepatients
AT marshallgradisniksonya transientreceptorpotentialmelastatin2channelsareoverexpressedinmyalgicencephalomyelitischronicfatiguesyndromepatients